MedCity News October 17, 2025
Check out news from Oral Genome, Planyear, Graph AI, Vega Health and more.
Oral Genome, a leader in salivary testing and oral-systemic health innovation, has announced new data showing its device achieves over 90% accuracy in detecting oral disease, including both periodontal disease and cavities. In a 2024 validation study, the Oral Genome device demonstrated:
Sensitivity (ability to detect disease): 89.7%
Specificity (ability to confirm health): 95%
Overall Accuracy (combined sensitivity & specificity): 92.4%
“These results confirm what we’ve been building toward – a simple, rapid, and highly reliable test that empowers both providers and patients with insights in under 15 minutes,” said Dr. Tina Saw, CEO and Founder of Oral Genome. “By integrating salivary testing with smartphones, we’re making oral health...
Today's Sponsors
Today's Sponsor